MedTrace Logo

Proton Therapy for Hodgkin Lymphoma

NCT00850200 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-01-31

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to reduce the risk of radiation related side effects and complications by treating with radiation (protons or photons) that exposes less of normal organs to low dose radiation.

Conditions

Interventions

RADIATION

Proton Radiation Plan

Between 21-39.6 Gy/CGE to the PTV

RADIATION

Conventional Photon Radiation Plan

Between 21-39.6 Gy/CGE to the PTV

RADIATION

Intensity Modulated Radiation Plan

Between 21-39.6 Gy/CGE to the PTV

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Bradford S Hoppe, MD, MPH · University of Florida Proton Therapy Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2013-05-31
Completion
2018-01-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00850200 on ClinicalTrials.gov